Testing the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy Treatment During Radiation Therapy for Superior Sulcus Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
Amgen
Henry Ford Health System
Bristol-Myers Squibb
GU Research Network, LLC
Emory University
Hoffmann-La Roche
Royal Marsden NHS Foundation Trust
University of Toledo
Incyte Corporation
Incyte Corporation
University of Texas Southwestern Medical Center
Hoffmann-La Roche
Loyola University
Eli Lilly and Company
Virginia Commonwealth University
M.D. Anderson Cancer Center
Case Comprehensive Cancer Center
Fox Chase Cancer Center
Spectrum Pharmaceuticals, Inc
AstraZeneca